SEVELAMER CARBONATE HEATON 800MG

QUALITATIVE AND QUANTITATIVE COMPOSITION

Each tablet contains 800 mg of carbonate carbonate.

Excipients: Each film-coated tablet contains 286.25 mg lactose monohydrate.

THERAPEUTIC INDICATIONS

Sevelamer Carbonate Heaton 800 mg is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.

Sevelamer Carbonate Heaton 800 mg is also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus ≥ 1.78 mmol/l.

Sevelamer Caarbonate Heaton 800 mg should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.

DISPENSING AND REIMBURSEMENT

Medicinal product is subjected to medical prescription. The medicinal product is covered by public health insurance.